137 related articles for article (PubMed ID: 21332270)
1. Peptidomimetics: modifying peptides in the pursuit of better vaccines.
Croft NP; Purcell AW
Expert Rev Vaccines; 2011 Feb; 10(2):211-26. PubMed ID: 21332270
[TBL] [Abstract][Full Text] [Related]
2. More than one reason to rethink the use of peptides in vaccine design.
Purcell AW; McCluskey J; Rossjohn J
Nat Rev Drug Discov; 2007 May; 6(5):404-14. PubMed ID: 17473845
[TBL] [Abstract][Full Text] [Related]
3. Getting peptide vaccines to work: just a matter of quality control?
Celis E
J Clin Invest; 2002 Dec; 110(12):1765-8. PubMed ID: 12488425
[No Abstract] [Full Text] [Related]
4. Epitope discovery and their use in peptide based vaccines.
Dudek NL; Perlmutter P; Aguilar MI; Croft NP; Purcell AW
Curr Pharm Des; 2010; 16(28):3149-57. PubMed ID: 20687873
[TBL] [Abstract][Full Text] [Related]
5. Designing B-Cell Epitopes for Immunotherapy and Subunit Vaccines.
Singh H; Gupta S; Gautam A; Raghava GP
Methods Mol Biol; 2015; 1348():327-40. PubMed ID: 26424284
[TBL] [Abstract][Full Text] [Related]
6. Rational design of peptide vaccines for autoimmune disease: harnessing molecular recognition to fix a broken network.
Weathington NM; Blalock JE
Expert Rev Vaccines; 2003 Feb; 2(1):61-73. PubMed ID: 12901598
[TBL] [Abstract][Full Text] [Related]
7. Peptides and peptidomimetics as immunomodulators.
Gokhale AS; Satyanarayanajois S
Immunotherapy; 2014; 6(6):755-74. PubMed ID: 25186605
[TBL] [Abstract][Full Text] [Related]
8. Virus-epitope vaccine design: informatic matching the HLA-I polymorphism to the virus genome.
Vider-Shalit T; Raffaeli S; Louzoun Y
Mol Immunol; 2007 Feb; 44(6):1253-61. PubMed ID: 16930710
[TBL] [Abstract][Full Text] [Related]
9. The role of structure in antibody cross-reactivity between peptides and folded proteins.
Craig L; Sanschagrin PC; Rozek A; Lackie S; Kuhn LA; Scott JK
J Mol Biol; 1998 Aug; 281(1):183-201. PubMed ID: 9680484
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of 2-alkoxy-8-hydroxyadenylpeptides: towards synthetic epitope-based vaccines.
Weterings JJ; Khan S; van der Heden GJ; Drijfhout JW; Melief CJ; Overkleeft HS; van der Burg SH; Ossendorp F; van der Marel GA; Filippov DV
Bioorg Med Chem Lett; 2006 Jun; 16(12):3258-61. PubMed ID: 16581248
[TBL] [Abstract][Full Text] [Related]
11. Peptide based vaccine design: synthesis and immunological characterization of branched polypeptide conjugates comprising the 276-284 immunodominant epitope of HSV-1 glycoprotein D.
Mezo G; Dalmadi B; Mucsi I; Bosze S; Rajnavölgyl E; Hudecz F
J Pept Sci; 2002 Mar; 8(3):107-17. PubMed ID: 11931583
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationships in peptide-antibody complexes: implications for epitope prediction and development of synthetic peptide vaccines.
Chen SW; Van Regenmortel MH; Pellequer JL
Curr Med Chem; 2009; 16(8):953-64. PubMed ID: 19275605
[TBL] [Abstract][Full Text] [Related]
13. Peptides for immunological purposes: design, strategies and applications.
Gori A; Longhi R; Peri C; Colombo G
Amino Acids; 2013 Aug; 45(2):257-68. PubMed ID: 23744401
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a reduced peptide bond analogue of a promiscuous CD4 T cell epitope derived from the Plasmodium falciparum malaria vaccine candidate merozoite surface protein 1.
Bastian M; Lozano JM; Patarroyo ME; Pluschke G; Daubenberger CA
Mol Immunol; 2004 Jul; 41(8):775-84. PubMed ID: 15234557
[TBL] [Abstract][Full Text] [Related]
15. A retro-inverso analog mimics the cognate peptide epitope of a CD4+ T cell clone.
Bartnes K; Hannestad K; Guichard G; Briand JP
Eur J Immunol; 1997 Jun; 27(6):1387-91. PubMed ID: 9209489
[TBL] [Abstract][Full Text] [Related]
16. Viral peptide immunogens: current challenges and opportunities.
Azizi A; Diaz-Mitoma F
J Pept Sci; 2007 Dec; 13(12):776-86. PubMed ID: 17853502
[TBL] [Abstract][Full Text] [Related]
17. Mimicry of viral epitopes with retro-inverso peptides of increased stability.
Benkirane N; Guichard G; Briand JP; Muller S; Brown F; Van Regenmortel MH
Dev Biol Stand; 1996; 87():283-91. PubMed ID: 8854029
[TBL] [Abstract][Full Text] [Related]
18. Peptide Amphiphile Micelles for Vaccine Delivery.
Barrett JC; Tirrell MV
Methods Mol Biol; 2018; 1798():277-292. PubMed ID: 29868967
[TBL] [Abstract][Full Text] [Related]
19. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of a multivalent, multiepitope vaccine construct.
Otvos L
Methods Mol Biol; 2008; 494():263-73. PubMed ID: 18726579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
